BackNeogenomics Overview
Neogenomics Inc.

Neogenomics Target Price

See Neogenomics's analyst price targets ($19) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$18.47

Average Target Price

$19.002.9% upside

1 analysts in the last 4 months

High: $19 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-29Craig-Hallum$192.9% upsideOpen
2026-04-29Leerink Partners$2535.4% upsideOpen
2026-02-24Piper Sandler$1329.6% downsideOpen
2025-10-28Leerink Partners$1424.2% downsideOpen
2025-09-02Stephens$1140.4% downsideOpen
2025-08-04Piper Sandler$1140.4% downsideOpen
2025-07-30Morgan Stanley$856.7% downsideOpen
2025-07-29Needham$856.7% downsideOpen
2025-05-06Piper SandlerDavid Westenberg$1235% downsideOpen
2025-01-11BTIGMark Massaro$182.5% downsideOpen
2024-07-30NeedhamMike Matson$192.9% upsideOpen
2024-05-02BTIGMark Massaro$2113.7% upsideOpen
2023-08-21StephensMason Carrico$182.5% downsideOpen
2022-08-17Piper SandlerDavid Westenberg$192.9% upsideOpen
2022-08-10Morgan Stanley$182.5% downsideOpen
2022-08-10Goldman Sachs$208.3% upsideOpen
2022-08-10Needham$1613.4% downsideOpen
2022-04-28Raymond James$1518.8% downsideOpen
2021-06-03Goldman SachsMatthew Sykes$55197.8% upsideOpen
2021-05-25GuggenheimSandy Draper$54192.4% upsideOpen

Neogenomics (NEO) FAQ

Neogenomics (NEO) currently reports a target price of $19. Use the charts on this page to explore Neogenomics's target price history and peer comparisons.

Analysts' average 12-month price target for Neogenomics is $19, about 2.9% upside from the current share price of $18.47. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $19, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neogenomics, and consider following NEO for alerts when major investors trade the stock.

Neogenomics is classified in the Healthcare sector. On target price, it currently shows $19. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NEO with unrelated industries.